97 related articles for article (PubMed ID: 10562498)
1. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2.
Aguirre AJ; Robertson ES
Virology; 1999 Nov; 264(2):359-69. PubMed ID: 10562498
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
5. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
[TBL] [Abstract][Full Text] [Related]
7. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
8. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
9. Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells.
Mũcke S; Polack A; Pawlita M; Zehnpfennig D; Massoudi N; Bohlen H; Doerfler W; Bornkamm G; Diehl V; Wolf J
Gene Ther; 1997 Feb; 4(2):82-92. PubMed ID: 9081710
[TBL] [Abstract][Full Text] [Related]
10. Detection and differentiation of Epstein-Barr virus strains by in situ polymerase chain reaction.
Tamaki H; Byron KS; Sullivan JL; Somasundaran M
Mol Cell Probes; 1997 Jun; 11(3):237-41. PubMed ID: 9232625
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
Lau SK; Chen YY; Berry GJ; Yousem SA; Weiss LM
Mod Pathol; 2003 Dec; 16(12):1242-7. PubMed ID: 14681325
[TBL] [Abstract][Full Text] [Related]
12. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
15. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4895-903. PubMed ID: 8763992
[TBL] [Abstract][Full Text] [Related]
16. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
17. Production of the immunosuppressive cytokine interleukin-10 by Epstein-Barr-virus-expressing pyothorax-associated lymphoma: possible role in the development of overt lymphoma in immunocompetent hosts.
Kanno H; Naka N; Yasunaga Y; Iuchi K; Yamauchi S; Hashimoto M; Aozasa K
Am J Pathol; 1997 Jan; 150(1):349-57. PubMed ID: 9006350
[TBL] [Abstract][Full Text] [Related]
18. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
[TBL] [Abstract][Full Text] [Related]
19. [Detection of Epstein-Barr virus genomes in various entities of low and high grade T-cell lymphomas].
Ott G; Ott MM; Gärtner C; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1992; 76():197-201. PubMed ID: 1283258
[TBL] [Abstract][Full Text] [Related]
20. Identification of two types of naturally-occurring intertypic recombinants of Epstein-Barr virus.
Kim SM; Kang SH; Lee WK
Mol Cells; 2006 Apr; 21(2):302-7. PubMed ID: 16682827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]